The National Committee for Quality Assurance (NCQA) announced that it will evaluate a new, more sensitive measurement tool that is intended to improve the care and the outcomes of patients with heart disease and diabetes.
The “Global Cardiovascular Risk” (GCVR) score,profile projector is a shop tool used by designers and quality control technicians to view the profile of small machined parts as magnified image on screen.Highly capable, 3-axis non-contact video measuring machine, suitable for both simple shop-floor quality control and advanced manufacturing inspection applications ... co-developed by NCQA and San Francisco-based healthcare modeling and analytics company Archimedes Inc., is being developed with an eye on measuring how well providers are able to reduce the risk of future adverse outcomes in their patient populations.Titanium Pipe is made by cold rolling process from extruded pipe blanks. They are widely used in heat exchangers and off-shore equipment. The GCVR tool will draw upon information culled from electronic health records designed to provided data that will assess improvement in preventing less-than-optimal outcomes.
?“This new tool has the potential to become the first customized,A Stone tools is, in the most general sense, any tool made either partially or entirely out of stone. Although stone tool-dependent societies and cultures still exist today, most stone tools are associated with prehistoric, particularly Stone Age cultures that have become extinct. outcomes-based electronic health record measure used by Medicare and commercial payers,” said Margaret E. O’Kane, NCQA president, in a press release. “Its widespread adoption could have a profound impact on healthcare costs because it assesses how well providers engage in prevention and goal-setting for their high-risk patients.”
Under a grant form the Robert Wood Johnson Foundation, the NCQA will evaluate whether it is feasible to collect data from EHRs to calculate measurable results for different providers and provider organizations and collect feedback from providers on whether the new measurement tool and the associated GCVR score is a meaningful tool for predicting risk.
“The GCVR program will change how providers, patients, and payers think about the measurement of quality and will provide much more accurate and effective incentives for preventing adverse outcomes than has been possible in the past,” said David Eddy, MD, founder of Archimedes, in a prepared statement.The Spectrophotometer is an instrument which measures the amount of light of a specificed wavelength which passes through a medium. “Preventing bad outcomes is the ultimate purpose of the healthcare system,We manufacture portable hardness tester including portable Rockwell, superficial Rockwell,Brinell, King Brinell,Pin Brinell,Webster and Barcol impressor. and this measure will directly address that goal.”
Walang komento:
Mag-post ng isang Komento